Synapse - Find an Expert

1017 Results

Studies on the role of an expanded intracellular vesicular system and protonation in pleiotropic drug resistance

Meeting Abstract

Munidi, J.; Young, C.; Grandi, M.; Giuliani, F.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

The calcium channel blocker-binding specificity of a 150-180 kDa surface membrane glycoprotein from multidrug-resistant cells

Meeting Abstract

Safa, A. R.; Glover, C. J.; Sewell, J. L.; Meyers, M. B.; Biedler, J. L.; Felsted, R. L.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Possible role for sorcin, a calcium binding protein overproduced in multidrug-resistant (MDR) cells

Meeting Abstract

Meyers, M. B.; Biedler, J. L.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Malignant to benign human colon tumor conversion by hexamethylene bisacetamide (HMBA)

Meeting Abstract

Schroy, P.; Carnright, K.; Winawer, S.; Friedman, E.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (HMBA) by 10 day continuous infusion (CI)

Meeting Abstract

Walsh, T. D.; Fanucchi, M. P.; Williams, L.; Lokos, G.; Stevens, Y. W.; Cassidy, C.; Young, C. W.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

A phase I clinical and pharmacokinetic study of merbarone (M)

Meeting Abstract

Haines, I.; Walsh, T. D.; Warrell, R. P. Jr; Stevens, Y. W.; Lowenthal, D.; Williams, L.; Sykes, M.; Young, C. W.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Recurrence in bone (B) versus recurrence at other sites (non-B) following adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF) chemotherapy (CT) for stage II and stage III breast cancer

Meeting Abstract

Cooper, K.; Scher, H. I.; Geller, N. L.; Chan, E. Y. W.; Reichman, B.; Hakes, T. B.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Treatment of poor risk nonseminomatous germ cell tumor (NSGCT) patients (pts) with carboplatin (CBDCA) + etoposide (E) + bleomycin (B)

Meeting Abstract

Motzer, R. J.; Bosl, G. J.; Yagoda, A.; Golbey, R.
Proceedings of the American Association for Cancer Research Annual Meeting (1987)

Fulltext@MSK | Save

Very high dose cisplatin (CDDP) with bleomycin (bleo) by 24-hour continuous infusion (CI) in advanced squamous cancer of the head and neck (SCHN): No dose-response relationship